Insurance; require coverage for healthcare services for pediatric autoimmune neuropsychiatric disorders; provisions
Summary
HB124 requires certain health insurance coverage for healthcare services related to pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS) and pediatric acute onset neuropsychiatric syndrome (PANS). The bill adds new provisions to Georgia’s insurance code and to the state employees’ health benefit laws, defining PANDAS, PANS, and “nationally recognized clinical practice guidelines,” and requiring that covered services be available for diagnosis, treatment, management, and ongoing monitoring when supported by those guidelines.
For private health benefit policies issued, delivered, renewed, or otherwise covered in Georgia on or after July 1, 2025, the bill mandates coverage for these services. For the State Health Benefit Plan, the mandate begins January 1, 2026, and applies to state and public employees, dependents, and retirees. In both settings, the bill allows the usual deductibles, coinsurance, and copayments that apply to other covered benefits, but it bars insurers and the state plan from imposing special deductibles or other special cost-sharing limits uniquely on PANDAS or PANS care.
Impact
HB124 would amend Title 33 and Title 45 of the Official Code of Georgia Annotated by creating new insurance coverage mandates for PANDAS and PANS. It affects most fully insured health benefit policies in Georgia and the State Health Benefit Plan, while expressly excluding self-insured plans governed by ERISA. The bill also authorizes the Insurance Commissioner to adopt rules and regulations to implement the new requirements and repeals conflicting laws.
Sentiment
The available voting history shows strong support for the bill: it passed the Georgia House 173-0 on February 24, 2025. No committee transcript is provided, so there is no recorded floor or committee debate in the supplied materials. The unanimous vote suggests broad bipartisan or cross-party agreement, at least in the House, on requiring coverage for these pediatric neuropsychiatric conditions.
Contention
The main policy issue embedded in the bill is whether insurers and the state health plan should be required to cover PANDAS and PANS services, and under what evidentiary standard. The bill addresses that concern by limiting coverage to services supported by nationally recognized clinical practice guidelines, which may reduce disputes over medically accepted treatment. Another potential point of contention is cost and scope: insurers and the state plan must cover the services, but cannot apply special cost-sharing restrictions, which could raise premium or budget concerns. The bill’s exclusion of ERISA self-insured plans also means coverage will not be uniform across all employer-sponsored insurance, which may be a practical limitation rather than a direct controversy.
A bill for an act relating to health insurance coverage for specified pediatric autoimmune neuropsychiatric disorders and postinfectious autoimmune encephalopathy.
A bill for an act relating to health insurance coverage for specified pediatric autoimmune neuropsychiatric disorders and postinfectious autoimmune encephalopathy.
State plan for medical assistance services and health insurance; pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute-onset neuropsychiatric syndrome.
Insurance: insurers; coverage for certain pediatric autoimmune neuropsychiatric disorders; require. Amends 1956 PA 218 (MCL 500.100 - 500.8302) by adding sec. 3406pp.
Removes the sunset provision of all statutory law requiring coverage for the treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections and pediatric acute onset neuropsychiatric syndrome.